Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Immunology | Hematology
Disease Category: Non-Hodgkin's Lymphoma
Location: United States, WV

Clinical Trial Details

Overview

Research Study Summary

S1001 - A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma

Purpose

Objective - To assess the 5-year progression-free survival rate in patients with newly diagnosed limited stage diffuse large B-cell lymphoma using PET/CT scan to direct therapy after 3 cycles of R-CHOP

See www.hsc.wvu.edu/mbrcc/ctru/ for additional information

To Learn more
Phase

3

Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Contact

West Virginia University - Clinical Trials Research Unit
1637 Health Sciences South, PO Box 9260
Morgantown, WV 26506
Phone: 304-293-7374

View Map

CW ID: 183644

Date Last Changed: July 16, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.